FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2915629824> ?p ?o ?g. }

• W2915629824 endingPage "574" @default.
• W2915629824 startingPage "563" @default.
• W2915629824 abstract "Immune checkpoint inhibitors (ICPis) are a novel class of immunotherapeutic agents that have revolutionized the treatment of cancer; however, these drugs can also cause a unique spectrum of autoimmune toxicity. Autoimmune hemolytic anemia (AIHA) is a rare, but often severe, complication of ICPis. We identified 14 patients from nine institutions across the United States who developed ICPi-AIHA. The median interval from ICPi initiation to development of AIHA was 55 days (interquartile range [IQR], 22-110 days). Results from the direct antiglobulin test (DAT) were available for 13 of 14 patients: 8 patients (62%) had a positive DAT and 5 (38%) had a negative DAT. The median pretreatment and nadir hemoglobin concentrations were 11.8 g/dL (IQR, 10.2-12.9 g/dL) and 6.3 g/dL (IQR, 6.1-8.0 g/dL), respectively. Four patients (29%) had a preexisting lymphoproliferative disorder, and two (14%) had a positive DAT prior to initiation of ICPi therapy. All patients were treated with glucocorticoids, with three requiring additional immunosuppressive therapy. Complete and partial recoveries of hemoglobin were achieved in 12 (86%) and 2 (14%) patients, respectively. Seven patients (50%) were rechallenged with ICPis, and one (14%) developed recurrent AIHA. Clinical and laboratory features of ICPi-AIHA were similar in DAT positive and negative patients. ICPi-AIHA shares many clinical features with primary AIHA; however, a unique aspect of ICPi-AIHA is a high incidence of DAT negativity. Glucocorticoids are an effective first-line treatment in the majority of patients with ICPi-AIHA, and most patients who are rechallenged with an ICPi do not appear to develop recurrence of AIHA." @default.
• W2915629824 created "2019-03-02" @default.
• W2915629824 creator A5000568350 @default.
• W2915629824 creator A5020460043 @default.
• W2915629824 creator A5022162371 @default.
• W2915629824 creator A5025067315 @default.
• W2915629824 creator A5031452560 @default.
• W2915629824 creator A5034548332 @default.
• W2915629824 creator A5035343389 @default.
• W2915629824 creator A5038157897 @default.
• W2915629824 creator A5043119087 @default.
• W2915629824 creator A5047098006 @default.
• W2915629824 creator A5052072704 @default.
• W2915629824 creator A5066250381 @default.
• W2915629824 creator A5069070706 @default.
• W2915629824 creator A5076456783 @default.
• W2915629824 creator A5080536692 @default.
• W2915629824 creator A5080783554 @default.
• W2915629824 creator A5084324197 @default.
• W2915629824 creator A5090769354 @default.
• W2915629824 date "2019-03-13" @default.
• W2915629824 modified "2023-10-17" @default.
• W2915629824 title "Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors" @default.
• W2915629824 cites W1503782472 @default.
• W2915629824 cites W1843065013 @default.
• W2915629824 cites W1967868228 @default.
• W2915629824 cites W1968412972 @default.
• W2915629824 cites W1976309343 @default.
• W2915629824 cites W2015085911 @default.
• W2915629824 cites W2023555404 @default.
• W2915629824 cites W2076067786 @default.
• W2915629824 cites W2096322385 @default.
• W2915629824 cites W2111143066 @default.
• W2915629824 cites W2117177996 @default.
• W2915629824 cites W2121149235 @default.
• W2915629824 cites W2151644715 @default.
• W2915629824 cites W2158425309 @default.
• W2915629824 cites W2259812842 @default.
• W2915629824 cites W2298823224 @default.
• W2915629824 cites W2323655202 @default.
• W2915629824 cites W2413514895 @default.
• W2915629824 cites W2468995962 @default.
• W2915629824 cites W2508205285 @default.
• W2915629824 cites W2509332865 @default.
• W2915629824 cites W2513322051 @default.
• W2915629824 cites W2547133566 @default.
• W2915629824 cites W2554931714 @default.
• W2915629824 cites W2560367415 @default.
• W2915629824 cites W2565491505 @default.
• W2915629824 cites W2572174216 @default.
• W2915629824 cites W2580311324 @default.
• W2915629824 cites W2586811241 @default.
• W2915629824 cites W2590277368 @default.
• W2915629824 cites W2600140285 @default.
• W2915629824 cites W2606872466 @default.
• W2915629824 cites W2673218446 @default.
• W2915629824 cites W2767579999 @default.
• W2915629824 cites W2783137027 @default.
• W2915629824 cites W2783864983 @default.
• W2915629824 cites W2786816161 @default.
• W2915629824 cites W2788726176 @default.
• W2915629824 cites W2789315292 @default.
• W2915629824 cites W2793167197 @default.
• W2915629824 cites W2793472260 @default.
• W2915629824 cites W2800825785 @default.
• W2915629824 cites W2804295877 @default.
• W2915629824 cites W2805530155 @default.
• W2915629824 cites W2877328171 @default.
• W2915629824 cites W2885717025 @default.
• W2915629824 cites W2891486030 @default.
• W2915629824 cites W2898022640 @default.
• W2915629824 cites W2902822641 @default.
• W2915629824 doi "https://doi.org/10.1002/ajh.25448" @default.
• W2915629824 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30790338" @default.
• W2915629824 hasPublicationYear "2019" @default.
• W2915629824 type Work @default.
• W2915629824 sameAs 2915629824 @default.
• W2915629824 citedByCount "44" @default.
• W2915629824 countsByYear W29156298242019 @default.
• W2915629824 countsByYear W29156298242020 @default.
• W2915629824 countsByYear W29156298242021 @default.
• W2915629824 countsByYear W29156298242022 @default.
• W2915629824 countsByYear W29156298242023 @default.
• W2915629824 crossrefType "journal-article" @default.
• W2915629824 hasAuthorship W2915629824A5000568350 @default.
• W2915629824 hasAuthorship W2915629824A5020460043 @default.
• W2915629824 hasAuthorship W2915629824A5022162371 @default.
• W2915629824 hasAuthorship W2915629824A5025067315 @default.
• W2915629824 hasAuthorship W2915629824A5031452560 @default.
• W2915629824 hasAuthorship W2915629824A5034548332 @default.
• W2915629824 hasAuthorship W2915629824A5035343389 @default.
• W2915629824 hasAuthorship W2915629824A5038157897 @default.
• W2915629824 hasAuthorship W2915629824A5043119087 @default.
• W2915629824 hasAuthorship W2915629824A5047098006 @default.
• W2915629824 hasAuthorship W2915629824A5052072704 @default.
• W2915629824 hasAuthorship W2915629824A5066250381 @default.
• W2915629824 hasAuthorship W2915629824A5069070706 @default.
• W2915629824 hasAuthorship W2915629824A5076456783 @default.

• next